A series of new studies led by scientists at The Scripps Research Institute (TSRI) and the International AIDS Vaccine Initiative (IAVI) describe a potential vaccination strategy to jump-start the selection and evolution of broadly effective antibodies to prevent HIV infection.
Read More![](https://wilson.scripps.edu/wp-content/uploads/2016/09/hiv3-1.jpg)